Urinary tract infections in girls: The cost-effectiveness of currently recommended investigative routines

被引:50
作者
Stark, H
机构
[1] Department of Pediatric Nephrology, Western Galilee Regional Hospital, Nahariya
关键词
urinary tract infection; girls; prognosis; investigation; imaging; cost-effectiveness;
D O I
10.1007/s004670050252
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Current recommendations for the universal investigation of urinary tract infection (UTI) in children by ultrasonography, voiding cystourethrography, mercaptosuccinic acid renal scan (and sometimes intravenous pyelography as well) are not based on any convincing evidence as to the necessity or effectiveness of such a routine. Over 8% of all girls will have a UTI during childhood. About 87 individuals in a million will develop end-stage renal disease (ESRD) by the age of 60 years, caused in about 9% by pyelonephritis (PN) or reflux nephropathy. From these statistics, the maximal risk of a first diagnosed UTI progressing to ESRD is approximately 1:10,000. The risk of developing hypertension following a first UTI in childhood, without eventual evolution to ESRD, appears to be very small. The cost of the widely recommended routine imaging procedures ranges from U.S. $ 355 in Britain to U.S. $ 1,090 in the United States. The minimal cost of preventing a single progression to ESRD by early diagnosis of underlying pathology - if this were possible in all cases - would range between U.S. $ 5 million in Britain and U.S. $ 15 million in the United States. Since in many instances progressive renal damage can not be prevented, the true cost is considerably higher. Lower UTI in girls is a very common and, in most cases, benign finding in primary-care practice. It is suggested that girls with afebrile UTI, presenting with lower urinary tract symptoms alone, need not undergo any imaging procedures, but should be followed with urine examinations and cultures at the time of febrile illness. The recommended investigative routines should be reserved for UTI in infants and in girls with fever or other symptoms suggesting PN, and for proven recurrent Un. Such a regimen will allow a marked saving in terms of costs and in terms of unneccessary radiation, psychological stress to children, and stress, inconvenience, and time loss to parents. There is no evidence that this approach will compromise the course or final outcome of this very common condition.
引用
收藏
页码:174 / 177
页数:4
相关论文
共 50 条
  • [31] Cost and radiation exposure in the workup of febrile pediatric urinary tract infections
    Michaud, Jason E.
    Gupta, Natasha
    Baumgartner, Timothy S.
    Kim, Brian
    Bosemani, Thangamadhan
    Wang, Ming-Hsien
    JOURNAL OF SURGICAL RESEARCH, 2016, 203 (02) : 313 - 318
  • [32] Urine neutrophil gelatinase-associated lipocalin in girls with recurrent urinary tract infections
    Forster, Catherine S.
    Loechtenfeldt, Allison M.
    Shah, Samir S.
    Goldstein, Stuart
    PEDIATRIC NEPHROLOGY, 2020, 35 (11) : 2121 - 2128
  • [33] Urine neutrophil gelatinase-associated lipocalin in girls with recurrent urinary tract infections
    Catherine S. Forster
    Allison M. Loechtenfeldt
    Samir S. Shah
    Stuart Goldstein
    Pediatric Nephrology, 2020, 35 : 2121 - 2128
  • [34] Cost-effectiveness of a pro-active approach of urinary incontinence in women
    Vermeulen, K. M.
    Visser, E.
    Messelink, E. J.
    Schram, A. J.
    Berger, M. Y.
    de Bock, G. H.
    Dekker, J. H.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (07) : 1213 - 1220
  • [35] Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections
    Lobo Borba, Helena Hiemisch
    Steimbach, Laiza Maria
    Riveros, Bruno Salgado
    Tonin, Fernanda Stumpf
    Ferreira, Vinicius Lins
    de Queiros Bagatim, Bruna Aline
    Balan, Gisele
    Pontarolo, Roberto
    Wiens, Astrid
    MYCOSES, 2018, 61 (10) : 754 - 763
  • [36] A trial-based cost-effectiveness analysis of antibiotic prescription strategies for non-complicated respiratory tract infections in children
    Gemma Mas-Dalmau
    María José Pérez-Lacasta
    Pablo Alonso-Coello
    Pedro Gorrotxategi-Gorrotxategi
    Emma Argüelles-Prendes
    Oscar Espinazo-Ramos
    Teresa Valls-Duran
    María Encarnación Gonzalo-Alonso
    María Pilar Cortés-Viana
    Tatiana Menéndez-Bada
    Marta Esther Vázquez-Fernández
    Ana Isabel Pérez-Hernández
    Laura Muñoz-Ortiz
    Carmen Villanueva-López
    Paul Little
    Mariam de la Poza-Abad
    Misericòrdia Carles-Lavila
    BMC Pediatrics, 23
  • [37] A trial-based cost-effectiveness analysis of antibiotic prescription strategies for non-complicated respiratory tract infections in children
    Mas-Dalmau, Gemma
    Perez-Lacasta, Maria Jose
    Alonso-Coello, Pablo
    Gorrotxategi-Gorrotxategi, Pedro
    Arguelles-Prendes, Emma
    Espinazo-Ramos, Oscar
    Valls-Duran, Teresa
    Gonzalo-Alonso, Maria Encarnacion
    Cortes-Viana, Maria Pilar
    Menendez-Bada, Tatiana
    Vazquez-Fernandez, Marta Esther
    Perez-Hernandez, Ana Isabel
    Munoz-Ortiz, Laura
    Villanueva-Lopez, Carmen
    Little, Paul
    de la Poza-Abad, Mariam
    Carles-Lavila, Misericordia
    BMC PEDIATRICS, 2023, 23 (01)
  • [38] Assessing cost-effectiveness with equity of a programme targeting marginalised girls in secondary schools in Tanzania
    Sabates, Ricardo
    Rose, Pauline
    Alcott, Benjamin
    Delprato, Marcos
    JOURNAL OF DEVELOPMENT EFFECTIVENESS, 2021, 13 (01) : 28 - 46
  • [39] Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections
    Lin, Hsin-An
    Yang, Ya-Sung
    Wang, Jing-Xun
    Lin, Hsin-Chung
    Lin, De-Yu
    Chiu, Chun-Hsiang
    Yeh, Kuo-Ming
    Lin, Jung-Chung
    Chang, Feng-Yee
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (02) : 237 - 242
  • [40] Cost-effectiveness of WHO-Recommended Algorithms for TB Case Finding at Ethiopian HIV Clinics
    Adelman, Max W.
    McFarland, Deborah A.
    Tsegaye, Mulugeta
    Aseffa, Abraham
    Kempker, Russell R.
    Blumberg, Henry M.
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (01):